CollabRx News

« All News Items

CollabRx Chairman Tenenbaum To Host Panel at Leading Personalized Medicine Meeting

Posted in CollabRx News by Rachael Kalicun on September 28, 2011 | No Comments »

CollabRx Chairman Marty Tenenbaum will chair a panel session entitled “Let’s Look at Cancer: What’s Happening in Personalized Medicine” at the 7th Annual Burrill & Company Personalized Medicine Meeting in October.

View the Burrill Personalized Medicine Meeting Agenda.

James Karis Joins CollabRx As CEO

Posted in CollabRx News by Rachael Kalicun on September 28, 2011 | No Comments »

Founder Marty Tenenbaum takes role of Chairman.

About CollabRx

CollabRx Scientists Jeff Shrager, Marty Tenenbaum, and Mike Travers Describe Cancer Commons in “Collaborative Computational Technologies for Biomedical Research”

Posted in CollabRx News, Publications by Rachael Kalicun on July 12, 2011 | No Comments »

Methods, Processes, and Tools for Collaboration

“The time has come to fundamentally rethink how we handle the building of knowledge in biomedical sciences today. This book describes how the computational sciences have transformed into being a key knowledge broker, able to integrate and operate across divergent data types.”—Bryn Williams-Jones, Associate Research Fellow, Pfizer

The pharmaceutical industry utilizes an extended network of partner organizations in order to discover and develop new drugs, however there is currently little guidance for managing information and resources across collaborations. continue reading »

CollabRx Team Proposes Curing Cancer As New Grand Challenge for AI

Posted in CollabRx News by Rachael Kalicun on July 12, 2011 | No Comments »

CollabRx CEO Marty Tenenbaum and CTO Jeff Shrager describe Cancer Commons and propose curing cancer as a new Grand Challenge for AI in the latest issue of AI Magazine.

Read Abstract or Download Complete PDF.

Unexpected Death of Director and Chief Medical Officer, John G. Curd, MD

Posted in CollabRx News by Rachael Kalicun on April 22, 2011 | No Comments »

A Statement from Marty Tenenbaum

The entire team of staff, board members and advisors at CollabRx is saddened by the unexpected passing of our friend and colleague, John G. Curd, MD. As our consulting Chief Medical Officer, Dr. Curd played an invaluable role in making CollabRx what it is today. Dr. Curd’s intelligence and professional aptitude elevated the entire cancer research community, and will be dearly missed. Our thoughts are with Dr. Curd’s family and friends during this difficult time.